Moleac is a biopharmaceutical company based in Singapore (Republic of Singapore).

We bring together the best of Asian and Western medicines: We identify promising medicine discovered in China and develop them into Western mainstream medicine. Conversely we develop and market in Asia innovative technologies and medical products that we in-license from Europe.

Our first brand of Dietary Supplements is Neuroaid™ is derived from Traditional Chinese Medicine and targets Neurological Support Functions.. It has gained market approval in two countries in 2006 and we plan to make it available to stroke sufferers around the world in 2007-2008. Our smoking cessation therapy will also reach main markets in 2008. In 2007 we have launched a simplified version of Neuroaid, based on its 10 main ingredients, Neuroaid10™ is thus compliant with FDA Dietary Supplements guidelines and was introduced in the USA in December 2007.

We focus our research and development resources in areas where patients' needs are greatest. We own a pipeline of drug and devices in various stages of development to address unmet medical needs and improve people's lives for which we drive development and registration. We seek partners to bring these products to market. We continue to evaluate additional opportunities.

Moleac is headquartered in Singapore. Its operations and research are located in Biopolis, a world-class purpose built complex for biomedical sciences research www.biopolis.com.sg

Overview

Asian medicine and research presents a large pool of marketed therapeutics and drugs under developments that can fill gaps in the western therapeutic arsenal by providing therapies to treat successfully unaddressed patients needs..

Since setting up in 2002, Moleac research has focused on identifying and clinically validating innovative drugs and devices in China, developing and marketing these outside China. Moleac started by in-licensing promising marketed Traditional Chinese Medicine products and is now extending its scope, by partnering with leading institutes in China to develop promising molecules into international markets.

Moleac has highly experienced and dedicated scientific and management teams. We bring together the world's top scientists in traditional medicines, molecular biology, pharmacology to carry out our research and development. Our management comprises senior executives and seasoned entrepreneurs experienced in taking drug development from laboratory to market. They bring with them extensive experience in business and product development, project management, operations, legal and licensing and intellectual property patents.

We have established partnerships with leading research institutes in Europe, China and Singapore. This has enabled us to identify therapeutics with excellent potential in both worlds; our multi-disciplinary and multi-continent team brings the key capabilities and credentials to drive successfully these opportunities.